Navigation Links
Non-Illuminated Trial Lens Set

ProductsNon-Illuminated Trial Lens Set
Company Khosla Medical & Surgical, Inc.
Item Non-Illuminated Trial Lens Set
Features Lenses are of plano form, back vertex power, 20 mm aperture spun into aluminum mounts Of 38 mm diameter. Plus and minus mounts are anodized in different colors. Handles are provided on spheres, but not on cylinders and prisms. Packed in carrying case. The lens tray rises on lifting the lid and it is a non-Illuminated, compact model
Description Non-Illuminated Trial Lens Set is an attractive set of trial lenses worked to a high standard of accuracy.
Info Khosla Medical & Surgical, Inc.
Customer Service: (408) 996 0205
Web site: http://www.khosla-med.com/

Related medicine products :

1. Khosla Mini Non-Illuminated Trial Lens Set, With Lenses Mounted
2. Khosla Non-Illuminated Trial Lens Set, With Lenses Mounted
3. Seven Trial Rings
4. Fresnel Trial Sets
5. Adult Trial Frame
6. Half Eye Trial Frame - Adult
7. Half Eye Trial Frame - Child
8. Classic Trial Frames UB3
9. Universal Trial Frames UB4
10. Childrens Half Trial Frames
11. Half Trial Frames
... contains 10% Povidone Iodine USP, 1% available ... pre-operative prep, Povidone Iodine Gel helps to ... the patient, thus reducing the chance of ... as a one step gel for venipuncture ...
... Scrub is a gentle and effective surgical ... dryness. Povidone Iodine is known to kill ... bacteria, fungi, viruses, protozoa and yeasts. It ... step in patient pre-operative prepping, as well ...
... Topical Gel is a viscous antimicrobial that ... Iodine for broad-spectrum germicidal action. As a ... to minimize the pooling of prepping solutions ... of patient burns. Povidone Iodine Topical Gel ...
... four ounce bottles are designed ... of procedural kit and tray ... been custom molded to Aplicare ... perfectly. This product has broad-spectrum ...
Medicine Products:
(Date:3/29/2017)... CT (PRWEB) , ... March 29, 2017 , ... HealthCareMandA.com ... —on Thursday, April 20, 2017, at 1:00 PM ET. A recording of the webinar ... the Interactive Webinar Series. , Home health and hospice companies are still popular targets ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one ... cancers and is touted to be the next revolution in our fight against this ... in the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , ...
(Date:3/29/2017)... PA (PRWEB) , ... March ... ... eastern suburbs and South Hills of Pittsburgh now have easier access to ... Pennsylvania only by Allegheny Health Network (AHN). Orthopaedic surgeons at Forbes Hospital ...
(Date:3/29/2017)... ... ... The Wharton School of the University of Pennsylvania is pleased to announce that ... gift to establish the Ken Moelis and Julie Taffet Moelis Advance Access Program ... for highly-qualified Penn undergraduates whose academic and career interests expand traditional notions of business ...
(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over 1.5 million SharePoint ... option for on-premises installation of its Help System for SharePoint was at the farm ... into the entire tenant. , The company recently released a modified version of ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Wound care devices and products are used ... The industry mainly consists of establishments engaged in manufacturing ... wounds caused by mechanical, chemical, thermal, and radiogenic trauma; ... diabetes, skin related diseases, immunological diseases, and other chronic ... the largest region in the wound care devices market ...
(Date:3/29/2017)... YORK , March 29, 2017 Global intravenous ... US$ 3 billion by 2021, growing at a CAGR of ... iron prescribed by a doctor to treat anemia or other ... iron level in the body. However, in some cases, oral ... the body and intravenous (IV) iron therapy comes into the ...
(Date:3/29/2017)... 2017  Novartis announced today that the US ... company,s Biologics License Application (BLA) filing and granted ... antigen receptor T cell (CAR-T) therapy, in relapsed ... with B-cell acute lymphoblastic leukemia (ALL). This is ... CAR-T. The priority review designation is expected to ...
Breaking Medicine Technology: